Last reviewed · How we verify
TNFa Kinoid
At a glance
| Generic name | TNFa Kinoid |
|---|---|
| Sponsor | Neovacs |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients (PHASE2)
- Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists (PHASE2)
- Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TNFa Kinoid CI brief — competitive landscape report
- TNFa Kinoid updates RSS · CI watch RSS
- Neovacs portfolio CI